Welcome to LookChem.com Sign In|Join Free
  • or
4-(Butylamino)-benzoic acid, methyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

71839-12-8

Post Buying Request

71839-12-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

71839-12-8 Usage

Uses

Methyl 4-(Butylamino)benzoate is used as a reactant in organic synthesis.

Check Digit Verification of cas no

The CAS Registry Mumber 71839-12-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,1,8,3 and 9 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 71839-12:
(7*7)+(6*1)+(5*8)+(4*3)+(3*9)+(2*1)+(1*2)=138
138 % 10 = 8
So 71839-12-8 is a valid CAS Registry Number.
InChI:InChI=1/C12H17NO2/c1-3-4-9-13-11-7-5-10(6-8-11)12(14)15-2/h5-8,13H,3-4,9H2,1-2H3

71839-12-8 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • USP

  • (1650028)  Tetracaine Related Compound C  United States Pharmacopeia (USP) Reference Standard

  • 71839-12-8

  • 1650028-25MG

  • 14,500.98CNY

  • Detail

71839-12-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name Methyl 4-(butylamino)benzoate

1.2 Other means of identification

Product number -
Other names 4-butylamino-benzoic acid methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:71839-12-8 SDS

71839-12-8Synthetic route

tri-n-butylindium
15676-66-1

tri-n-butylindium

4-methoxycarbonylbenzenediazonium o-benzenedisulfonimide

4-methoxycarbonylbenzenediazonium o-benzenedisulfonimide

A

o-benzenedisulfonimide
4482-01-3

o-benzenedisulfonimide

B

N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

Conditions
ConditionsYield
In tetrahydrofuran at 20 - 25℃;A n/a
B 92%
Methyl 4-chlorobenzoate
1126-46-1

Methyl 4-chlorobenzoate

N-butylamine
109-73-9

N-butylamine

N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

Conditions
ConditionsYield
With di-tert-butyl{2′-isopropoxy-[1,1′-binaphthalen]-2-yl}phosphane; caesium carbonate; palladium diacetate In 1,2-dimethoxyethane at 110℃; for 16h;91%
With 1,4-diaza-bicyclo[2.2.2]octane; nickel(II) bromide dimethoxyethane; tris(2,2-bipyridine)ruthenium(II) hexafluorophosphate In dimethyl sulfoxide at 80℃; for 1h; Flow reactor; Sealed tube; Schlenk technique; Inert atmosphere; Irradiation;65%
methyl 4-iodobenzoate
619-44-3

methyl 4-iodobenzoate

N-butylamine
109-73-9

N-butylamine

N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

Conditions
ConditionsYield
Stage #1: methyl 4-iodobenzoate With copper(l) iodide; L-proline In dimethyl sulfoxide at 20℃; for 0.0833333h; Ullmann-Goldberg Substitution; Inert atmosphere;
Stage #2: N-butylamine In dimethyl sulfoxide at 20℃; for 17h; Ullmann-Goldberg Substitution; Inert atmosphere;
91%
methyl 4-butyramidobenzoate
356100-70-4

methyl 4-butyramidobenzoate

N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

Conditions
ConditionsYield
With borane-ammonia complex; boron trifluoride diethyl etherate; tris(pentafluorophenyl)borate In 1,2-dichloro-ethane at 60℃; for 16h;84%
n-butyllithium
109-72-8, 29786-93-4

n-butyllithium

C12H16N2O2S
581798-27-8

C12H16N2O2S

N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

Conditions
ConditionsYield
In diethyl ether; hexane at -78 - 25℃; for 0.833333h;67%
N-butylamine
109-73-9

N-butylamine

4-methoxycarbonyl aniline
619-45-4

4-methoxycarbonyl aniline

N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

Conditions
ConditionsYield
With palladium on activated charcoal In tetrahydrofuran at 170℃; for 1.5h; Microwave irradiation;34%
Stage #1: N-butylamine; 4-methoxycarbonyl aniline In ethanol for 2h; Reflux;
Stage #2: With sodium tetrahydroborate In methanol at 0 - 20℃; for 2h;
30%
methanol
67-56-1

methanol

4-butylamino-benzoyl chloride ; hydrochloride

4-butylamino-benzoyl chloride ; hydrochloride

N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

Conditions
ConditionsYield
With diethyl ether
butyraldehyde
123-72-8

butyraldehyde

4-methoxycarbonyl aniline
619-45-4

4-methoxycarbonyl aniline

N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

Conditions
ConditionsYield
With acetic acid; zinc; benzene
methanol
67-56-1

methanol

4-(N-butylamino)benzoic acid
4740-24-3

4-(N-butylamino)benzoic acid

N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

Conditions
ConditionsYield
With sulfuric acid Heating;
4-methoxycarbonylbenzenediazonium o-benzenedisulfonimide

4-methoxycarbonylbenzenediazonium o-benzenedisulfonimide

N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: NaOMe / methanol
1.2: 80 percent / methanol / 0.5 h / 20 - 25 °C
2.1: 67 percent / diethyl ether; hexane / 0.83 h / -78 - 25 °C
View Scheme
4-methoxycarbonyl aniline
619-45-4

4-methoxycarbonyl aniline

N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: triethylamine / dichloromethane / 14 h / 0 - 20 °C
2: caesium carbonate / N,N-dimethyl-formamide / 2 h / 90 °C
3: potassium carbonate / methanol / 1 h / 70 °C
View Scheme
methyl 4-(2,2,2-trifluoroacetamido)benzoate
304646-56-8

methyl 4-(2,2,2-trifluoroacetamido)benzoate

N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: caesium carbonate / N,N-dimethyl-formamide / 2 h / 90 °C
2: potassium carbonate / methanol / 1 h / 70 °C
View Scheme
C14H16F3NO3

C14H16F3NO3

N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

Conditions
ConditionsYield
With potassium carbonate In methanol at 70℃; for 1h;702.6 mg
methyl 4-butyramidobenzoate
356100-70-4

methyl 4-butyramidobenzoate

A

N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

B

4-methoxycarbonyl aniline
619-45-4

4-methoxycarbonyl aniline

Conditions
ConditionsYield
With [bis(2-methylallyl)cycloocta-1,5-diene]ruthenium(II); formic acid; bis(trifluoromethanesulfonyl)amide; triethylamine; [2-((diphenylphospino)methyl)-2-methyl-1,3-propanediyl]bis[diphenylphosphine] In dibutyl ether at 130℃; for 24h; Overall yield = 83 percent; Overall yield = 43 mg;
2-bromo-1-cycloheptene-1-carboxylic acid
90002-61-2

2-bromo-1-cycloheptene-1-carboxylic acid

N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

methyl 4-(2-bromo-N-butylcyclohept-1-ene-1-carboxamido)benzoate
1616681-30-1

methyl 4-(2-bromo-N-butylcyclohept-1-ene-1-carboxamido)benzoate

Conditions
ConditionsYield
Stage #1: 2-bromo-1-cycloheptene-1-carboxylic acid With oxalyl dichloride; N,N-dimethyl-formamide In dichloromethane at 20℃; for 0.166667h;
Stage #2: N-(n-butyl)-4-methoxycarbonylaniline With dmap In dichloromethane at 60℃; for 2h;
97%
2-bromo-1-cyclopentene-1-carboxylic acid
1506-75-8

2-bromo-1-cyclopentene-1-carboxylic acid

N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

methyl 4-(2-bromo-N-butylcyclopent-1-ene-1-carboxamido)benzoate
1616681-26-5

methyl 4-(2-bromo-N-butylcyclopent-1-ene-1-carboxamido)benzoate

Conditions
ConditionsYield
Stage #1: 2-bromo-1-cyclopentene-1-carboxylic acid With oxalyl dichloride; N,N-dimethyl-formamide In dichloromethane at 20℃; for 0.166667h;
Stage #2: N-(n-butyl)-4-methoxycarbonylaniline With dmap In dichloromethane at 60℃; for 2h;
92%
N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

benzylamine
100-46-9

benzylamine

C18H22N2O
1470025-87-6

C18H22N2O

Conditions
ConditionsYield
With [m-(1,4-diazabicyclo[2.2.2]octanekN1:kN4)]hexamethyldialuminum In tetrahydrofuran at 130℃; for 0.133333h; Inert atmosphere; Microwave irradiation;91%
N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

Propargylamine
2450-71-7

Propargylamine

C14H18N2O
1470025-88-7

C14H18N2O

Conditions
ConditionsYield
With [m-(1,4-diazabicyclo[2.2.2]octanekN1:kN4)]hexamethyldialuminum In tetrahydrofuran at 130℃; for 0.133333h; Inert atmosphere; Microwave irradiation;89%
2-bromocyclohex-1-enecarboxylic acid
68965-62-8

2-bromocyclohex-1-enecarboxylic acid

N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

methyl 4-(2-bromo-N-butylcyclohex-1-ene-1-carboxamido)benzoate
1616681-28-7

methyl 4-(2-bromo-N-butylcyclohex-1-ene-1-carboxamido)benzoate

Conditions
ConditionsYield
Stage #1: 2-bromocyclohex-1-enecarboxylic acid With oxalyl dichloride; N,N-dimethyl-formamide In dichloromethane at 20℃; for 0.166667h;
Stage #2: N-(n-butyl)-4-methoxycarbonylaniline With dmap In dichloromethane at 60℃; for 2h;
84%
2-(N,N-dimethylamino)ethanol
108-01-0

2-(N,N-dimethylamino)ethanol

N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

tetracaine hydrochloride
136-47-0

tetracaine hydrochloride

Conditions
ConditionsYield
Stage #1: 2-(N,N-dimethylamino)ethanol; N-(n-butyl)-4-methoxycarbonylaniline With sodium methylate at 130℃; for 8h;
Stage #2: With hydrogenchloride
83%
isocyanic acid (3-nitro-phenyl) ester
3320-87-4

isocyanic acid (3-nitro-phenyl) ester

N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

methyl 4-[1-butyl-3-(3-nitrophenyl)ureido]benzoate

methyl 4-[1-butyl-3-(3-nitrophenyl)ureido]benzoate

Conditions
ConditionsYield
In dichloromethane at 20℃; Inert atmosphere;80%
2-bromo-1-cyclooctene-1-carboxylic acid
1259296-21-3

2-bromo-1-cyclooctene-1-carboxylic acid

N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

methyl 4-(2-bromo-N-butylcyclooct-1-ene-1-carboxamido)benzoate
1616681-32-3

methyl 4-(2-bromo-N-butylcyclooct-1-ene-1-carboxamido)benzoate

Conditions
ConditionsYield
Stage #1: 2-bromo-1-cyclooctene-1-carboxylic acid With oxalyl dichloride; N,N-dimethyl-formamide In dichloromethane at 20℃; for 0.166667h;
Stage #2: N-(n-butyl)-4-methoxycarbonylaniline With dmap In dichloromethane at 60℃; for 2h;
56%
Malonic acid monomethyl ester
16695-14-0

Malonic acid monomethyl ester

N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

N-butyl-N-(4-methoxycarbonylphenyl)-α-carbomethoxyacetamide
155257-37-7

N-butyl-N-(4-methoxycarbonylphenyl)-α-carbomethoxyacetamide

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane 15 min, 0 deg C then r.t., 5 h;
N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

C11H17N3O

C11H17N3O

Conditions
ConditionsYield
With hydrazine hydrate for 0.5h; Heating;
N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

1-butyl-5-(methoxycarbonyl)-2(3H)-indolinone

1-butyl-5-(methoxycarbonyl)-2(3H)-indolinone

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: DMAP, DCC / CH2Cl2 / 15 min, 0 deg C then r.t., 5 h
2: MeSO2N3, DBU / acetonitrile / 0 deg C, 30 min then r.t.
3: 50 percent / 50 molpercent Nafion-H / toluene / 28 h / Heating
View Scheme
N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

N-butyl-N-(4-methoxycarbonylphenyl)-α-carbomethoxy-α-diazoacetamide
148518-83-6

N-butyl-N-(4-methoxycarbonylphenyl)-α-carbomethoxy-α-diazoacetamide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: DMAP, DCC / CH2Cl2 / 15 min, 0 deg C then r.t., 5 h
2: MeSO2N3, DBU / acetonitrile / 0 deg C, 30 min then r.t.
View Scheme
N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

1-(4-carbomethoxyphenyl)-3-carbomethoxy-4-propyl-2-azetidinone

1-(4-carbomethoxyphenyl)-3-carbomethoxy-4-propyl-2-azetidinone

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: DMAP, DCC / CH2Cl2 / 15 min, 0 deg C then r.t., 5 h
2: MeSO2N3, DBU / acetonitrile / 0 deg C, 30 min then r.t.
3: 10 percent / 50 molpercent Nafion-H / toluene / 28 h / Heating
View Scheme
N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

methyl 5-butyl-4-oxo-2,3,4,5-tetrahydro-1H-cyclopenta[c]quinoline-8-carboxylate
1616681-34-5

methyl 5-butyl-4-oxo-2,3,4,5-tetrahydro-1H-cyclopenta[c]quinoline-8-carboxylate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: oxalyl dichloride; N,N-dimethyl-formamide / dichloromethane / 0.17 h / 20 °C
1.2: 2 h / 60 °C
2.1: palladium diacetate; caesium carbonate; tricyclohexylphosphine tetrafluoroborate / N,N-dimethyl acetamide / 4 h / 130 °C
View Scheme
N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

methyl 5-butyl-6-oxo-5,6,7,8,9,10-hexahydrophenanthridine-2-carboxylate
1616681-36-7

methyl 5-butyl-6-oxo-5,6,7,8,9,10-hexahydrophenanthridine-2-carboxylate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: oxalyl dichloride; N,N-dimethyl-formamide / dichloromethane / 0.17 h / 20 °C
1.2: 2 h / 60 °C
2.1: palladium diacetate; caesium carbonate; tricyclohexylphosphine tetrafluoroborate / N,N-dimethyl acetamide / 4 h / 130 °C
View Scheme
N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

methyl 5-butyl-6-oxo-6,7,8,9,10,11-hexahydro-5H-cyclohepta[c]quinoline-2-carboxylate
1616681-38-9

methyl 5-butyl-6-oxo-6,7,8,9,10,11-hexahydro-5H-cyclohepta[c]quinoline-2-carboxylate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: oxalyl dichloride; N,N-dimethyl-formamide / dichloromethane / 0.17 h / 20 °C
1.2: 2 h / 60 °C
2.1: palladium diacetate; caesium carbonate; tricyclohexylphosphine tetrafluoroborate / N,N-dimethyl acetamide / 4 h / 130 °C
View Scheme
N-(n-butyl)-4-methoxycarbonylaniline
71839-12-8

N-(n-butyl)-4-methoxycarbonylaniline

methyl 5-butyl-6-oxo-5,6,7,8,9,10,11,12-octahydrocycloocta[c]quinoline-2-carboxylate
1616681-40-3

methyl 5-butyl-6-oxo-5,6,7,8,9,10,11,12-octahydrocycloocta[c]quinoline-2-carboxylate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: oxalyl dichloride; N,N-dimethyl-formamide / dichloromethane / 0.17 h / 20 °C
1.2: 2 h / 60 °C
2.1: palladium diacetate; caesium carbonate; tricyclohexylphosphine tetrafluoroborate / N,N-dimethyl acetamide / 4 h / 130 °C
View Scheme

71839-12-8Relevant academic research and scientific papers

Visible Light-Mediated (Hetero)aryl Amination Using Ni(II) Salts and Photoredox Catalysis in Flow: A Synthesis of Tetracaine

Park, Boyoung Y.,Pirnot, Michael T.,Buchwald, Stephen L.

, p. 3234 - 3244 (2020/02/04)

We report a visible light-mediated flow process for C-N cross-coupling of (hetero)aryl halides with a variety of amine coupling partners through the use of a photoredox/nickel dual catalyst system. Compared to the method in batch, this flow process enables a broader substrate scope, including less-activated (hetero)aryl bromides and electron-deficient (hetero)aryl chlorides, and significantly reduced reaction times (10 to 100 min). Furthermore, scale up of the reaction, demonstrated through the synthesis of tetracaine, is easily achieved, delivering the C-N cross-coupled products in consistently high yield of 84% on up to a 10 mmol scale.

Ru-Catalyzed Deoxygenative Transfer Hydrogenation of Amides to Amines with Formic Acid/Triethylamine

Pan, Yixiao,Luo, Zhenli,Xu, Xin,Zhao, Haoqiang,Han, Jiahong,Xu, Lijin,Fan, Qinghua,Xiao, Jianliang

supporting information, p. 3800 - 3806 (2019/07/12)

A ruthenium(II)-catalyzed deoxygenative transfer hydrogenation of amides to amines using HCO2H/NEt3 as the reducing agent is reported for the first time. The catalyst system consisting of [Ru(2-methylallyl)2(COD)], 1,1,1-tris(diphenylphosphinomethyl) ethane (triphos) and Bis(trifluoromethane sulfonimide) (HNTf2) performed well for deoxygenative reduction of various secondary and tertiary amides into the corresponding amines in high yields with excellent selectivities, and exhibits high tolerance toward functional groups including those that are reduction-sensitive. The choice of hydrogen source and acid co-catalyst is critical for catalysis. Mechanistic studies suggest that the reductive amination of the in situ generated alcohol and amine via borrowing hydrogen is the dominant pathway. (Figure presented.).

B(C6F5)3-Catalyzed Deoxygenative Reduction of Amides to Amines with Ammonia Borane

Pan, Yixiao,Luo, Zhenli,Han, Jiahong,Xu, Xin,Chen, Changjun,Zhao, Haoqiang,Xu, Lijin,Fan, Qinghua,Xiao, Jianliang

supporting information, p. 2301 - 2308 (2019/01/30)

The first B(C6F5)3-catalyzed deoxygenative reduction of amides into the corresponding amines with readily accessible and stable ammonia borane (AB) as a reducing agent under mild reaction conditions is reported. This metal-free protocol provides facile access to a wide range of structurally diverse amine products in good to excellent yields, and various functional groups including those that are reduction-sensitive were well tolerated. This new method is also applicable to chiral amide substrates without erosion of the enantiomeric purity. The role of BF3 ? OEt2 co-catalyst in this reaction is to activate the amide carbonyl group via the in situ formation of an amide-boron adduct. (Figure presented.).

Synthesis and Pharmacological Evaluation of Selective Histone Deacetylase 6 Inhibitors in Melanoma Models

Tavares, Maurício T.,Shen, Sida,Knox, Tessa,Hadley, Melissa,Kutil, Zsófia,Ba?inka, Cyril,Villagra, Alejandro,Kozikowski, Alan P.

supporting information, p. 1031 - 1036 (2017/10/18)

Only a handful of therapies offer significant improvement in the overall survival in cases of melanoma, a cancer whose incidence has continued to rise in the past 30 years. In our effort to identify potent and isoform-selective histone deacetylase (HDAC) inhibitors as a therapeutic approach to melanoma, a series of new HDAC6 inhibitors based on the nexturastat A scaffold were prepared. The new analogues 4d, 4e, and 7b bearing added hydrophilic substituents, so as to establish additional hydrogen bonding on the rim of the HDAC6 catalytic pocket, exhibit improved potency against HDAC6 and retain selectivity over HDAC1. Compound 4d exhibits antiproliferative effects on several types of melanoma and lymphoma cells. Further studies indicates that 4d selectively increases acetylated tubulin levels in vitro and elicits an immune response through down-regulating cytokine IL-10. A preliminary in vivo efficacy study indicates that 4d possesses improved capability to inhibit melanoma tumor growth and that this effect is based on the regulation of inflammatory and immune responses.

Room-Temperature Practical Copper-Catalyzed Amination of Aryl Iodides

Deldaele, Christopher,Evano, Gwilherm

, p. 1319 - 1328 (2016/04/20)

An efficient and highly practical procedure is reported for the Ullmann-Goldberg-type copper-catalyzed amination of aryl iodides. By using a combination of copper iodide and proline in the presence of an excess of an amine, a wide range of aryl iodides can be readily aminated at room temperature. The reaction proceeds well regardless of the electronic properties of the starting aryl iodide and the amination products can be obtained without the need for purification by column chromatography in most cases. Owing to its efficiency and the mildness of the reaction conditions, this amination could also be extended to the amination of complex aryl iodides at room temperature.

Structure-activity relationship study of non-steroidal NPC1L1 ligands identified through cell-based assay using pharmacological chaperone effect as a readout

Karaki, Fumika,Ohgane, Kenji,Fukuda, Hiromitsu,Nakamura, Masahiko,Dodo, Kosuke,Hashimoto, Yuichi

, p. 3587 - 3609 (2014/07/07)

Niemann-Pick type C1-like 1 (NPC1L1) is an intestinal cholesterol transporter that is known to be the target of the cholesterol absorption inhibitor ezetimibe. We previously discovered steroidal NPC1L1 ligands by using a novel cell-based assay that employs pharmacological chaperone effect as a readout. Those steroid derivatives bound to a site different from both the sterol-binding domain and the ezetimibe-binding site, implying that they may be a novel class of NPC1L1 inhibitors with a distinct mode of action. As an extension of that work, we aimed here to find non-steroidal NPC1L1 ligands, which may be better candidates for clinical application than steroidal ligands, by using the same assay to screen our focused library of ligands for liver X receptor (LXR), a nuclear receptor that recognizes oxysterols as endogenous ligands. Here we describe identification of a novel class of NPC1L1 ligands with a ring-fused quinolinone scaffold, and an analysis of the structure-activity relationships of their derivatives as NPC1L1 ligands.

Use of primary amines for the selective n-alkylation of anilines by a reusable heterogeneous catalyst

Linciano, Pasquale,Pizzetti, Marianna,Porcheddu, Andrea,Taddei, Maurizio

, p. 2249 - 2254 (2013/11/06)

Traditionally, anilines can be alkylated with reactive alkyl halides but now more safe reagents such as alcohols or even amines can be used. To overcome the limits of homogeneous catalysis for aniline N-alkylation, we have developed a protocol that employs simple Pd/C as a heterogeneous catalyst under microwave dielectric heating. The process, based on the easy Pd-mediated oxidation of primary amines to imines followed by aniline addition, is characterized by a high atom economy as ammonia is the only other product of the reaction. This kind of aniline alkylation with amines has been carried out both in ionic liquid medium using [bmim]PF6 or in a more traditional solvent such as THF where the catalyst could be successfully recycled more times. The reusability of the catalyst was further confirmed by using material recycled from the amination in a standard alkene hydrogenation without loss of efficiency. Georg Thieme Verlag Stuttgart New York.

SUBSTITUTED SULFONAMIDES USEFUL AS ANTIAPOPTOTIC BCL INHIBITORS

-

Page/Page column 222, (2012/12/13)

Disclosed are compounds of Formula (I), or a pharmaceutically acceptable salt thereof, wherein: W and Q and G are defined herein. Also disclosed are methods of using such compounds as inhibitors of Bcl-2 family antiapoptotic proteins for the treatment of cancer; and pharmaceutical compositions comprising such compounds.

Reactions of arenediazonium o-benzenedisulfonimides with aliphatic triorganoindium compounds

Barbero, Margherita,Cadamuro, Silvano,Dughera, Stefano,Ghigo, Giovanni

scheme or table, p. 862 - 868 (2009/04/11)

The reaction of various arenediazonium o-benzenedisulfonimides with aliphatic triorganoindium compounds is described. Surprisingly, with triethyl- or tributylindium we obtained N-ethyl- or N-butylanilines, respectively. This is the first case in which, at least formally, the reactive site of a diazonium salt is the nitrogen atom directly bonded to the aromatic ring. In contrast, with trimethylindium we obtained only formaldehyde (aryl)hydrazones. In order to explain the difference between trimethyl- and triethylindium we have proposed some reaction mechanisms, supported by detailed density functional (DFT) calculations. The possible role of diazene/hydrazone tautomerism initially assumed was discarded and therefore three mechanisms for the key step (nucleophilic addition of the trialkylindium to the N=N double bond of diazene) were studied. For the favoured mechanism there is a difference in the energy barriers of 2 kcalmol-1 between the reactions with trimethyl- and triethylindium. This difference is explained on the basis of the different C-In bond energies in the two organometallics and it is assumed to be enough to explain their different behaviour under the experimental conditions. Wiley-VCH Verlag GmbH & Co. KGaA, 2008.

A new class of nifuroxazide analogues: Synthesis of 5-nitrothiophene derivatives with antimicrobial activity against multidrug-resistant Staphylococcus aureus

Masunari, Andrea,Tavares, Leoberto Costa

, p. 4229 - 4236 (2008/03/13)

Hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) has been an increasing problem worldwide since the initial reports over 40 years ago. To examine new drug leads with potential antibacterial activities, 14 p-substituted benzoic acid [(5-nitro-thiophen-2-yl)-methylene]-hydrazides were designed, synthesized, and tested against standard and multidrug-resistant S. aureus strains by serial dilution tests. All compounds exhibited significant bacteriostatic activity and some of them also showed bactericidal activity. The results confirmed the potential of this class of compounds as an alternative for the development of selective antimicrobial agents.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 71839-12-8